断层弹性成像用于测量胰腺导管腺癌中与组织硬度相关的肿瘤体积
多中心前瞻性研究纳入102名参与者(30名健康者、72例经组织学证实的胰腺导管腺癌患者),采用多频磁共振弹性成像联合断层弹性成像后处理生成剪切波速度图。胰腺导管腺癌组织剪切波速度高于健康胰腺组织和肿瘤旁非肿瘤胰腺组织,断层弹性成像可定量肿瘤体积并与CT及离体大体标本体积相关。
要点
- 胰腺导管腺癌组织剪切波速度(2.08±0.38 m/s)高于健康胰腺组织(1.25±0.09 m/s)和肿瘤旁非肿瘤胰腺组织(1.28±0.14 m/s)。
- 阈值1.47 m/s区分胰腺导管腺癌组织与健康志愿者(AUC=1.0,敏感度=100%,特异度=100%)。
- 阈值1.49 m/s区分胰腺导管腺癌组织与肿瘤旁非肿瘤胰腺组织(AUC=0.99,敏感度=90%,特异度=100%)。
关键影像表现/征象
- 断层弹性成像在99%的病例中可定量肿瘤体积,CT在87%的病例中可定量肿瘤体积。
- 胰腺剪切波速度重复性高(重复性系数=0.12),且不随区域、患者年龄、性别或体重指数变化(所有P>0.08)。
- 胰腺导管腺癌组织剪切波速度为2.08±0.38 m/s,高于健康参与者的1.25±0.09 m/s(P<0.001)和胰腺导管腺癌患者肿瘤旁非肿瘤胰腺组织的1.28±0.14 m/s(P<0.001)。
诊断标准与关键数值
- 阈值1.47 m/s区分胰腺导管腺癌组织与健康志愿者:AUC=1.0,敏感度=100%,特异度=100%。
- 阈值1.49 m/s区分胰腺导管腺癌组织与肿瘤旁非肿瘤胰腺组织:AUC=0.99,敏感度=90%,特异度=100%。
- 断层弹性成像所得肿瘤体积与CT体积相关(r=0.91,P<0.001),与离体肿瘤体积相关(r=0.66,P<0.001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Estimations of tumor volume and boundary in pancreatic ductal adenocarcinoma (PDAC) are crucial for surgery planning. The aim of the study is to evaluate tomoelastography for detection of PDAC and quantification of PDAC volume based on tissue stiffness.
MATERIALS AND METHODS: From March 2018 to December 2019, a total of 102 participants (30 healthy participants and 72 patients with histologically proven PDAC) were prospectively enrolled in a multicenter study. Multifrequency magnetic resonance elastography was combined with tomoelastography postprocessing to generate maps of shear wave speed (SWS) depicting highly resolved anatomical details of tissue stiffness. Subregional analysis of pancreatic head, body, and tail and reproducibility tests were performed in healthy participants, whereas tumorous (PDAC-T) and nontumorous (PDAC-NT) pancreatic tissue analysis was conducted in patients. In all patients, tumor volumes measured by computed tomography (CT) were compared with SWS-derived volumes. In addition, in 32 patients, tumor sizes were evaluated by macroscopy after resection.
RESULTS: Tumor volumes were quantified in 99% and 87% of all cases with tomoelastography and CT, respectively. Pancreatic SWS was highly reproducible (repeatability coefficient = 0.12) and did not vary regionally or with patient age, sex, or body mass index (all P > 0.08). Shear wave speed was higher in PDAC-T (2.08 ± 0.38 m/s) than in healthy (1.25 ± 0.09 m/s; P < 0.001) and PDAC-NT (1.28 ± 0.14 m/s; P < 0.001) participants. A threshold of 1.47 m/s separated PDAC-T from healthy volunteers (area under the curve = 1.0, sensitivity = 100%, specificity = 100%), while 1.49 m/s separated PDAC-T from PDAC-NT with high accuracy (area under the curve = 0.99, sensitivity = 90%, specificity = 100%). Tomoelastography-derived tumor volume correlated with CT volume (r = 0.91, P < 0.001) and ex vivo tumor volume (r = 0.66, P < 0.001).
CONCLUSIONS: Tomoelastography provides a quantitative imaging marker for tissue stiffness depicting PDAC boundaries and separates PDAC from unaffected pancreatic tissue.
引用
- Marticorena Garcia SR, Zhu L, Gültekin E, et al. Tomoelastography for Measurement of Tumor Volume Related to Tissue Stiffness in Pancreatic Ductal Adenocarcinomas. Invest Radiol. 2020. PMID: 32796197. doi:10.1097/RLI.0000000000000704
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。